| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |